GEN Exclusives

More »

GEN News Highlights

More »
Mar 3, 2014

Sartorius Reports 7.7% Revenue Growth for Fiscal 2013

  • Joachim Kreuzburg, Ph.D., CEO of the Sartorius Group, told a press conference that the company achieved all financial targets for fiscal 2013, including growth of 7.7% in consolidated sales revenue of €887.3 million (around $1.22 billion), up from €845.7 million (approximately $1.16 billion) a year ago. He also pointed out that Sartorius’ bioprocess solutions division expanded its portfolio for the biopharma market by acquisitions and its own product development.

    “In the lab products & services division, we launched a number of promising new product series and at the same time we phased out a few nonstrategic product lines,” he said.

    Dr. Kreuzburg noted that operating profit rose 7.1% and the company’s profit margin reached 19.5%. The number of employees grew to over than 6,000. Sartorius expects sales to grow approximately 8% to 10% in constant currencies for 2014, he added.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?